Remicade, Lyophilisat

7680551840015 CH-55184 Lyophilisat
Remicade, Lyophilisat
Remicade, Lyophilisat
Remicade, Lyophilisat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lyophilisat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/08/2025
Summary of Product Characteristics
Français
19/08/2025
Summary of Product Characteristics
Italien
19/08/2025

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
1.943 MG Substance HBESI

Reimbursement information

Public price
CHF 565.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2000

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
55184
Drug name
Remicade, Lyophilisat
Galenic form
LSPA
ATC Code
L04AB02
Authorization status
Z
Dispensing category
A
First authorization
21/12/1999
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis

Package details

Description (FR)
REMICADE subst sèche 100 mg flac
Description (DE)
REMICADE Trockensub 100 mg Durchstf
Market launch
21/12/1999
Narcotic (BTM)
No